CAR-T Cell Therapy Market to Grow at CAGR of 33.11% through 2026
Increasing prevalence of cancer and widespread research activities are expected to drive global CAR-T Cell Therapy Market According to TechSci Research report, “Global CAR-T Cell Therapy Market, By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel), Abecma (idecabtagene vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-cell… Read More »